Skip to main content
IDDO Logo
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
  • Data
    • Explore data
    • Accessing data
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
    • Data Access Guidelines
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
  • About us
    • About us
    • Governance
    • IDDO Team
    • Our partners
    • Contact us
  • Data
    • Explore data
    • Accessing data
    • Contributing data
    • Why share your data
    • Frequently Asked Questions
    • IDDO legal and regulatory documentation
    • Data Access Guidelines
  • Science
    • Science
    • WWARN malaria
    • Visceral leishmaniasis
    • COVID-19
    • Medicine Quality
    • Antimicrobial Resistance
    • Schistosomiasis & STHs
    • Chagas Disease
    • Ebola
    • Febrile illness
    • Scrub typhus
    • Trachoma
    • Other diseases
  • Equity
    • Our approach
    • IDDO Blogs
  • News
  • Publications
LOGIN
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

All Tools and Resources

Site handling of monitoring visits

Procedure

 

Soil-transmitted helminthiases systematic review - study and cohort-level data

Document

Soil-transmitted helminthiases systematic review - study arm-level data

Document

Soil-transmitted helminthiases systematic review - variable dictionary

Document

Standard operating procedure management

Procedure

 

 

Statistical analysis plan

Document

Statistical Analysis Plan DHA-PQP Dose Impact Study Group. Version 1.9

Document

Statistical Analysis Plan Vivax Paediatric Primaquine

Document

Statistical Analysis Plan WWARN Vivax Haematology Study Group

Document

Studies with Day 3 Parasitaemia Positivity Rates above 10%

Document

Pagination

  • First page « First
  • Previous page ‹‹ Prev
  • …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Current page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • Next page Next ››
  • Last page Last »

  • Navigation
    • About
  • Contact
    • info@iddo.org
  • Socials
    • LinkedIn
  • Newsletters
    • IDDO Newsletter
IDDO Footer logo
© 2026 Infectious Diseases Data Observatory
  • Cookies |
  • Privacy Notice |
  • Accessibility |
  • Sitemap |
  • Terms of use